Trifarotene (Aklief) - A New Topical Retinoid for Acne

Date: December 16, 2019 Issue #:  1587Summary:  The FDA has approved trifarotene 0.005% cream (Aklief– Galderma) for topical treatment of acne vulgaris in patients ≥9 years old. Trifarotene is the fourth topical retinoid to be approved in the US for treatment of acne; tretinoin (Retin-A, and others), adapalene (Differin, and generics), and tazarotene (Tazorac, and others) have been available by prescription for decades. Adapalene 0.1% gel has been available over the counter since 2016 for treatment of acne in patients ≥12 years old.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Tags: Acne Adapalene Aklief Atralin Avita Benzoyl peroxide Biacna Clindamycin Differin Epiduo Retin-A Retinoids Stieva Tactupump Tazarotene Tazorac Tretinoin trifarotene Veltin Ziana Source Type: research